Christopher Fortier is the Manager of Pharmacy Support Services at the Medical University of South Carolina and a Clinical Assistant Professor with the South Carolina College of Pharmacy MUSC Campus. Dr. Fortier received his Doctor of Pharmacy degree from the University of Connecticut and completed both a PGY-1 Practice Residency and a PGY-2 Health-System Pharmacy Administration Residency at the Medical University of South Carolina Medical Center.

As the Manager of Pharmacy Support Services he oversees procurement/contracting, controlled substances, repackaging, compounding, given-in-clinic, and investigational drug services. Dr. Fortier also has lead the implementation of bar code medication administration, smart infusions pumps, and medication reconciliation across the organization.

Dr. Fortier served on the ASHP New Practitioners Forum Executive Committee for two years, serving as the vice-chair in 2006-2007. Additionally, with the New Practitioners Forum he chaired the Communications and Public Affairs Advisory Group (2005-2007) and was a member of the Leadership and Career Development Advisory Group (2003-2005, 2007-2008). As a member of the ASHP Practice Manager Section he serves as the immediate-past chair on the sections Leadership Development Advisory Group (2005-present). Additionally, he is a representative on the ASHP Foundation's Center for Health-System Pharmacy Leadership Student & New Practitioner Leadership Task Force (2007-present). Dr. Fortier is also involved with the University HealthSystem Consortium's (UHC) Pharmacy Council in which he is a member of the Pharmacy Council's Executive Committee and chairs the Medication Use Informatics and Technology Committee.

Dr. Taber is currently a clinical pharmacy specialist working in the area of solid organ transplant and has about 10 years of experience in this field. He also coordinates clinical pharmacy services at MUSC for the critical care and surgery service area. Recently, Dr. Taber has coordinated efforts to establish an antimicrobial stewardship program at MUSC. Dr. Taber's research interests include studying outcomes associated with drug utilization in transplant recipients and antimicrobial utilization, especially in the realm of antivirals. He has published over 15 manuscripts in this area and is currently a principle investigator or co-principle invesigator for several large research grants.

Dr. Taber earned his B.S. in Pharmacy from SUNY Buffalo in 1996 and his Pharm.D. from MUSC in 1999. He completed specialized residency training in solid organ transplantation from UNC Chapel Hill in 2000. Dr. Taber has been a practicing board certified pharmacotherapy specialist since 2000.